Jaysynth Orgochem Limited carries a market capitalization of 1.73B, placing it among publicly traded companies globally. Its enterprise value stands at 1.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.73B |
| Enterprise Value | 1.47B |
Jaysynth Orgochem Limited currently has 134.91M shares outstanding.
| Shares Outstanding | 134.91M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Jaysynth Orgochem Limited trades at a trailing price-to-earnings ratio of 8.87. The price-to-sales ratio is 0.50, and the price-to-book ratio stands at 9.64.
| PE Ratio | 8.87 |
| PS Ratio | 0.50 |
| PB Ratio | 9.64 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Jaysynth Orgochem Limited trades at an EV/EBITDA multiple of 7.60 and an EV/FCF ratio of 124.08. The EV/Sales ratio of 0.57 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.60 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.57 |
| EV / EBITDA | 7.60 |
| EV / EBIT | 7.60 |
| EV / FCF | 124.08 |
Jaysynth Orgochem Limited maintains a current ratio of 4.17, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 31.38, indicating elevated leverage, while an interest coverage ratio of 11.56 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.17 |
| Quick Ratio | 0.55 |
| Debt / Equity | 31.38 |
| Debt / EBITDA | 2.17 |
| Interest Coverage | 11.56 |
Jaysynth Orgochem Limited posts a return on equity of 21.25 and a return on invested capital of 8.94.
| Return on Equity (ROE) | 21.25 |
| Return on Assets (ROA) | 6.89 |
| Return on Invested Capital (ROIC) | 8.94 |
| Return on Capital Employed (ROCE) | 16.87 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.13 |
Over the trailing twelve months, Jaysynth Orgochem Limited has paid 60.36M in income taxes, reflecting an effective tax rate of 29.17.
| Income Tax | 60.36M |
| Effective Tax Rate | 29.17 |
Jaysynth Orgochem Limited's stock has declined approximately -42.86988% over the past 52 weeks. The 50-day moving average sits at 13.12, while the 200-day moving average is 14.59.
| Beta (5Y) | N/A |
| 52-Week Price Change | -42.86988% |
| 50-Day Moving Average | 13.12 |
| 200-Day Moving Average | 14.59 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Jaysynth Orgochem Limited generated 2.60B in revenue and converted that into 146.58M in net income, yielding earnings per share of 1.09. EBITDA reached 193.29M, while operating income came in at 193.29M.
| Revenue | 2.60B |
| Gross Profit | 823.44M |
| Operating Income | 193.29M |
| Pretax Income | 206.94M |
| Net Income | 146.58M |
| EBITDA | 193.29M |
| EBIT | 193.29M |
| Earnings Per Share (EPS) | 1.09 |
Jaysynth Orgochem Limited holds 249.60M in cash and equivalents against 419.47M in total debt, resulting in a net debt position of 390.13M. Total book value stands at 134.91M, with working capital of 1.45B providing operational flexibility.
| Cash & Cash Equivalents | 249.60M |
| Total Debt | 419.47M |
| Net Debt | 390.13M |
| Equity (Book Value) | 134.91M |
| Book Value Per Share | 1.00 |
| Working Capital | 1.45B |
Jaysynth Orgochem Limited operates with a gross margin of 31.71, reflecting its pricing power and cost economics. The operating margin of 7.44 and net profit margin of 5.64 provide insight into operational efficiency.
| Gross Margin | 31.71 |
| Operating Margin | 7.44 |
| Pretax Margin | 7.97 |
| Profit Margin | 5.64 |
| EBITDA Margin | 7.44 |
Jaysynth Orgochem Limited posts an Altman Z-Score of 3.19, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.19 |